Article Information
History
- March 7, 2023.
Article Versions
- You are currently viewing Version 1 of this article (March 7, 2023 - 08:24).
- Version 2 (June 1, 2023 - 09:19).
- Version 3 (August 23, 2023 - 07:19).
- View Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- M Tomasicchio1,2,
- S Jaumdally1,2,
- A Pooran1,2,
- A Esmail1,2,
- L Wilson1,2,
- A Kotze1,2,
- L Semple1,2,
- S Meier1,2,
- K Pillay5,
- R Roberts5,
- R Kriel5,
- R Meldau1,2,
- S Oelofse1,2,
- C Mandviwala1,2,
- J Burns1,2,
- R Londt1,2,
- M Davids1,2,
- C van der Merwe1,2,
- A Roomaney1,2,
- L Kühn1,2,
- T Perumal1,2,
- A.J Scott1,2,
- M.J Hale6,
- V Baillie7,
- S Mahtab7,
- C Williamson8,
- R Joseph8,
- A Sigal9,
- I Joubert10,
- J Piercy10,
- D Thomson10,
- DL Fredericks10,
- MGA Miller10,
- M Nunes7,
- S.A Madhi7 and
- K Dheda1,2,3,4,*
- 1Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine, University of Cape Town and UCT Lung Institute, Cape Town, South Africa
- 2South African MRC Centre for the Study of Antimicrobial Resistance, University of Cape Town, Cape Town, South Africa
- 3Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa
- 4Faculty of Infectious and Tropical Diseases, Department of Immunology and Infection, London School of Hygiene & Tropical Medicine, London, UK
- 5Division of Anatomical Pathology, Department of Pathology, University of Cape Town, Cape Town, South Africa
- 6Division of Anatomical Pathology, Faculty of Health Sciences, University of the Witwatersrand
- 7South African Medical Research Council, Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Technology/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
- 8Division of Medical Virology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
- 9Africa Health Research Institute, Durban, South Africa
- 10Division of Critical Care, Department of Anaesthesia and Perioperative Medicine, University of Cape Town, South Africa
- ↵*Correspondence: Keertan Dheda, Centre for Lung Infection and Immunity, Division of Pulmonology and UCT Lung Institute, Dept of Medicine, University of Cape Town, South Africa. E-mail: keertan.dheda{at}uct.ac.za
Posted March 07, 2023.
SARS-CoV-2 viral replication persists in the human lung for several weeks after onset of symptomatic severe COVID-19 and is associated with attenuated pulmonary immunity and variant-specific clinical sequalae
